AVNS

Avanos MedicalB

NYSE / Health Care Equipment & Services

At close

2026-07-18

Current thesis

If the AIP transaction closes as announced, investors collect the remaining merger spread, and Q1 SNS growth suggests the standalone asset base is not deteriorating quickly.

Posture

Constructive

Lead driver

Value

What changed

Value remains the lead driver in the composite, 7D delta +0.4.

What can break

Concentration risk: SNS strength is helping, but it does not fully offset weaker PM&R profitability on a break-deal basis.

Momentum

Value

Sentiment

Setup hits (3d)

— · Net —

AI TargetsBase $24.80 · Bull $25.00 · Bear $18.50

Data freshness

Prices

As of 2026-07-18

Fundamentals

As of 2026-07-17 • Vendor: Data Vendor v1

Scores

As of 2026-07-18 • Model: HYBRID_IC_RP

AI Memo

As of 2026-05-20 • Model: RankAlpha Sentiment Codex

Investment thesis

As of 2026-07-18

Supporting evidence

What

Grade B · Constructive

Confidence Medium · Net —

Target $20.00

Why

Momentum75 · Δ7d -8.8

Value55 · Δ7d +0.4

Sentiment52 · Δ7d -3.3

So what

Strength-led posture. Favor watchlist adds and disciplined entries.

Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits

Lead driver: Value · See fundamentals

Momentum

26% active weight

Current posture

7d trendImproving

Δ7d

-8.8

Δ21d

-10.7

Value

39% active weight

Current posture

7d trendFlat

Δ7d

+0.4

Δ21d

+0.5

Sentiment

34% active weight

Current posture

7d trendSoftening

Δ7d

-3.3

Δ21d

-1.8

Why this grade

Composite grade B. Momentum 74.9 / Value 54.5 / Sentiment 52.0

Fundamentals (TTM)

As of 2026-07-17

Market Cap

$1.17B

Beta

1.08

Shares Out

46.85M

P/E (TTM) · Derived

-15.9

P/S (TTM)

0.75

P/FCF (TTM)

7.01

Rev YoY

+8.8%

EPS YoY

-23.8%

Gross Margin

+48.6%

Op Margin

-69.0%

Net Debt

$39.3M

Current Ratio

2.48

As of 2026-07-18 • Updated nightlySource: Internal modelMethodology